Acid Reflux Disease
Research from P. Juulhansen and co-authors provides new data about acid reflux disease
Published in Medical Device Business Week, February 4th, 2009
"To compare an H2-blocker in an effervescent formulation with a PPI in on-demand treatment of endoscopy-negative gastro-oesophageal reflux disease (GERD). Included were patients with heartburn and/or acid regurgitation for at least 3 months duration, a negative endoscopy and a positive response to 7 days of lansoprazole 60 mg daily. Following pH-metry, the patients were randomized to receive either ranitidine effervescent tablets 75 mg or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Ambulatory Surgery
Cogdell Spencer Breaks Ground on Projects in Tennessee and North Carolina - Ambulatory Surgery
Researchers from Bristol-Myers Squibb Company detail new studies and findings in the area of ambulatory surgery - American Academy of Cosmetic Surgery
Patients Seek Quick Recovery From Cosmetic Procedures in Order to Return to Work Faster - ArthroCare Corp.
ArthroCare Obtains a Waiver of Default under Its Credit Agreement - AuthorHouse
'Putting for the Green': New Thrilling High Society Novel Revolves Around Mafia and High-Stakes Golf Tournament - Bederra Corp.
Bederra Corp. Selects EquityGroups.com to Create Awareness about Company - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
